Blog

Photo from Italian Association of Pediatric Hematology and Oncology/LinkedIn

Apr 26, 2024, 12:05

The final day of GIORNATE AIEOP 2024!

AIEOP: Italian Association of Pediatric Hematology and Oncology shared on LinkedIn:

“That concludes the final day of GIORNATE AIEOP 2024!

Thank you to all who joined, especially to the speakers who presented on various fields including neuroblastoma, immunodeficiencies, kidney tumors, new drugs, and psychosocial aspects of cancer and hematologic disorders.

A special thank you to:
– President Arcangelo Prete and the Board of Directors
– Scientific Secretariat: Angela Mastronuzzi, Marta Canesi and Elisa Tirtei
– Michela Vandi and Congress Planning.”

Soure: AIEOP: Italian Association of Pediatric Hematology and Oncology/LinkedIn

AIEOP Angela Mastronuzzi Arcangelo Prete cancer Congress Planning Elisa Tirtei hematologic disorders immunodeficiencies Italian Association of Pediatric Hematology and Oncology kidney tumors Marta Canesi Michela Vandi neuroblastoma new drugs OncoDaily Oncology Pediatric Hematology

FDA Priority Review Granted for TAR-200 After 82% Complete Response in BCG-Unresponsive Bladder Cancer

Paolo Tarantino: AACR Journals' Power Move for Reviewers

Best Immunotherapy Highlights from ESMO TAT ASIA 2025 You Shouldn't Miss

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership

Mohit Manrao: FDA Grants Priority Review for sBLA in Resectable Early-Stage Gastric and GEJ Cancers